Pre-fusion RSV F antigens

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12139512
APP PUB NO 20220332766A1
SERIAL NO

17848230

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to pre-fusion RSV F protein and polypeptides that contain one or more amino acid mutations that stabilize the pre-fusion conformation or destabilize the post-fusion conformation. The invention also relates to methods for inducing an immune response to pre-fusion RSV F.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLAXOSMITHKLINE BIOLOGICALS SA1330 RIXENSART

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carfi, Andrea Cambridge, US 34 323
Swanson, Kurt Newton, US 40 338

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 12, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 May 12, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 12, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00